Abstract
The recent report from the American Academy of Pediatrics on the prevention of iron deficiency and iron deficiency anemia recommended increased iron intake for breast fed infants beginning at 4 months of age. This recommendation has not been without controversy. This paper will review the reasoning behind these new recommendations and include a physiologic review of iron metabolism as well as its physiologic importance including its role in neurodevelopment. It will review the diagnosis of both iron deficiency and iron deficiency anemia and how to prevent them in the breastfed infant. This includes introducing medicinal iron at 4 months of age and introducing foods that are rich in heme iron (red meat) when complementary feedings are introduced.
Keywords: Infants, breastfeeding, iron deficiency, iron deficiency anemia, neuroedevelopment
Current Pediatric Reviews
Title:The Iron Requirement of Breastfeeding Infants
Volume: 8 Issue: 4
Author(s): Frank R. Greer
Affiliation:
Keywords: Infants, breastfeeding, iron deficiency, iron deficiency anemia, neuroedevelopment
Abstract: The recent report from the American Academy of Pediatrics on the prevention of iron deficiency and iron deficiency anemia recommended increased iron intake for breast fed infants beginning at 4 months of age. This recommendation has not been without controversy. This paper will review the reasoning behind these new recommendations and include a physiologic review of iron metabolism as well as its physiologic importance including its role in neurodevelopment. It will review the diagnosis of both iron deficiency and iron deficiency anemia and how to prevent them in the breastfed infant. This includes introducing medicinal iron at 4 months of age and introducing foods that are rich in heme iron (red meat) when complementary feedings are introduced.
Export Options
About this article
Cite this article as:
R. Greer Frank, The Iron Requirement of Breastfeeding Infants, Current Pediatric Reviews 2012; 8 (4) . https://dx.doi.org/10.2174/157339612803307741
DOI https://dx.doi.org/10.2174/157339612803307741 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis
Current Topics in Medicinal Chemistry Contemporary Treatment of Amyloid Heart Disease
Current Pharmaceutical Design Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Anti-Cancer Agents in Medicinal Chemistry Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Therapeutic Polycomb Targeting in Human Cancer
Recent Patents on Regenerative Medicine <sup>177</sup>Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Current Radiopharmaceuticals Infection, Stem Cells and Cancer Signals
Current Pharmaceutical Biotechnology Targeting Pathways Mediating Bone Disease
Current Pharmaceutical Biotechnology Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Smell and Taste Disorders Resulting from Cancer and Chemotherapy
Current Pharmaceutical Design Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Current Cancer Drug Targets Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments
Current Medicinal Chemistry Small Molecule Inhibitors of Multidrug Resistance Gene (MDR1) Expression: Preclinical Evaluation and Mechanisms of Action
Current Cancer Drug Targets System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector
Current Pharmaceutical Design Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
Current Medicinal Chemistry